Latest California Healthline Stories
Once-fatal childhood diseases, like cystic fibrosis, congenital heart disease and sickle cell anemia, now can be survived into adulthood. But when those patients become too old to see pediatricians, it can be difficult for them to find physicians familiar with their conditions.
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.”
Armed with strict guidelines and motivated by sheer urgency, a specialized team of nurses makes the rounds, seeking to thwart the No. 1 killer in U.S. hospitals.
The Seattle case, the first to reach trial in the U.S., offers possible glimpse into fate of some two dozen lawsuits against manufacturing giant Olympus, accused of failing to address scope contamination linked to numerous deaths. The company faults poor hospital cleaning practices.
This year’s American Diabetes Association scientific meeting comes with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients — those ages 51 to 60.
The researchers looked at 11 services that medical groups have said are often unnecessary and found that blacks and Hispanics got them at higher rates than whites.
Actions by the Trump administration are putting pressure on the fragile market for individuals who buy their own coverage, but analysts say it should be able to rebound.